Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Agencourt Responds to Market Demand for its Genomics Services by Expanding Sales and Marketing Teams.


Business Editors

BEVERLY, Mass.--(BUSINESS WIRE)--May 20, 2002

Former Integrated Genomics and MolecularWare, Inc. Business

Development Experts Join Agencourt

Agencourt Bioscience Corporation, a provider of genomic services and products to improve the effectiveness and efficiency of drug development pipelines, today announced the expansion of its marketing and sales forces with two key additions. Mann A. Shoffner joins the company as Senior Manager for Marketing and Business Development and Kerri Anne Stellato has been hired as Senior Sales Associate for the Midwest region.

As Senior Manager for Marketing and Business Development, Mr. Shoffner will direct and manage all strategic marketing efforts for all of Agencourt's services and product offerings, and assist Agencourt with its strategic partnerships. Prior to joining Agencourt, Mr. Shoffner served as the Director of Business Development at MolecularWare, Inc., where he was responsible for direct sales of the company's products, directed strategic business development and played an integral part in raising venture funding and managing product support. Previously, Mr. Shoffner served as International Sales Manager sales manager ngerente m/f de ventas

sales manager ndirecteur commercial

sales manager sale n
 at the Packard Instrument Company, now PerkinElmer Life Sciences.

As Senior Sales Associate, Ms. Stellato will be responsible for marketing Agencourt's genomic services and Solid Phase Reversible Immobilization Immobilization Definition

Immobilization refers to the process of holding a joint or bone in place with a splint, cast, or brace. This is done to prevent an injured area from moving while it heals.
 (SPRI SPRI Scott Polar Research Institute (University of Cambridge)
SPRI Single Ply Roofing Institute
SPRI Schering-Plough Research Institute (Corporate division) 
(TM)) technology to the Midwest region. Prior to joining Agencourt, Ms. Stellato was a Business Development Associate at Integrated Genomics, where she managed sales and developed new business opportunities for government and academic clients. Ms. Stellato also served as a Grant Coordinator, where she managed grant applications to federal and state agencies. Previously, she served as a Research Training Specialist at the University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey is the state-run health sciences institution of New Jersey and comprises eight distinct academic units: the New Jersey Medical School, the New Jersey Dental School, the Graduate School of Biomedical Sciences, the School of .

"We welcome Mann and Kerri to Agencourt as the demand for our SPRI services and solutions continues to grow exponentially," said Brian McKernan, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Agencourt. "Their expertise in the life sciences field will be instrumental to the continued success of our sales, marketing and business development."

About Agencourt Bioscience

Agencourt Bioscience Corporation is a provider of genomic services and products such as DNA Sequencing DNA sequencing

The determination of the sequence of nucleotides in a sample of DNA.
, SNP SNP Scottish National Party

Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily
 Genotyping and DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 Purification to the life sciences industry. Agencourt genomic solutions help biotech and pharmaceutical companies improve the effectiveness and efficiency of their drug development pipelines. Several of Agencourt's founders worked at the Whitehead Institute Center for Genome Research, and have significant experience in marrying the chemistries and instrumentation for high-throughput genomics. Agencourt is located in Beverly, Mass. and is available on the Web at www.agencourt.com.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 20, 2002
Words:403
Previous Article:Ensure Wins 2002 TEPR Award for Best Healthcare Security Solution; Ensure's XyLoc Wins Honor for Second Straight Year.
Next Article:NSI Software Selected by Southwest Corporate Federal Credit Union to Protect Customer and Business Data.



Related Articles
Agencourt Expands Sales Force to Meet Increased Demand for Its Industrialized Genomics Services and Solutions.
Duke University Medical Center Selects Agencourt Bioscience to Provide Genomic Services to Aid in Cancer Research.
Biomedical Industry Veteran Eugene Della Vecchia Joins Agencourt's Board of Directors.
Agencourt Bioscience Aids Duke University Medical Center Research in Perioperative Organ Dysfunction.
Agencourt Bioscience Provides Genomic Services to Leading Biopharmaceutical Company; Agencourt Enters Agreement to Provide Millennium Pharmaceuticals...
Genome Therapeutics Divests GenomeVision Services Unit to Agencourt Bioscience; Customers and Certain Personnel Expected to Transfer to...
Agencourt Bioscience and Lucigen Form Strategic Partnership for Product Distribution and Research Initiatives.
Agencourt Expands Sales Force to Meet Growing Demand for Its Discovery Solutions Suite of Genomics and Proteomic Services.
NHGRI Funds Agencourt for Large-Scale Genomic Sequencing Project; Genomics Services Company to Receive $27.2 Million over Three Years.
Agencourt Bioscience to Be Acquired by Beckman Coulter; Wholly-Owned Subsidiary to Continue to Focus on Genomic Services and Reagent Solutions.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles